Thoratec (THOR -3.8%) trades down after UBS cut the shares to Neutral from Buy on valuation. The...

|About: Thoratec Corporation (THOR)|By:, SA News Editor

Thoratec (THOR -3.8%) trades down after UBS cut the shares to Neutral from Buy on valuation. The firm says the stock may be played out over the near term, as peer competitor Heartware's (HTWR +1%) pending launch of HVAD is expected to cut into its heart therapy market share.